The Securities and Exchange Commission is investigating Kodak after a surge in the company’s stock just days before the Trump administration gave the company a $765 million loan under the Defense Production Act. The news led to Kodak’s stock value soaring by 1,000%. Kodak’s CEO was issued 1.75 million stock options a day before the announcement. The loan was given to help Kodak start making prescription drugs — something it has never done before.
Kodak Under Investigation for Insider Trading Tied to Massive Government Loan
HeadlineAug 06, 2020